BRIEF-Valeant Pharmaceuticals CEO won't rule out Bausch sale-CNBC

Wed Sep 7, 2016 4:48pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 7 (Reuters) -

* Valeant Pharmaceuticals CEO Joe Papa, speaking on CNBC, said he will 'never say never' on a potential sale of Valeant's Bausch + Lomb business, but is focused on selling non-core assets;

* Papa said the company has not set aside funds for investigations and lawsuits Further company coverage: (Reporting By Rod Nickel)